Grail’s Galleri blood test screens for multiple cancer types using a single blood draw, analyzing DNA fragments for cancer signals and predicting their likely origin. As the test moves closer to a potential FDA decision, five cancer specialists highlighted its promise for detecting cancers that…
The American Gastroenterological Association (AGA) has awarded $2.9 million to 84 researchers, reinforcing its long-standing role in shaping the future…
A Maricopa County jury sided with a gastroenterologist accused of failing to diagnose a fatal bowel obstruction, declining a $26.6…
Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting…
Olympus’ $1M+ equipment grant to ASGE isn’t just philanthropy—it’s a strategic investment in shaping the next generation of endoscopists and,…
DDW 2026
Several studies presented at DDW 2026 highlighted emerging approaches that could reshape…
A structured triage system for interventional GI referrals changed the originally requested…
Headlines in GI
Jiro Health has announced a content agreement with the American College of…
Lucid Diagnostics has begun receiving Medicare payments for its EsoGuard esophageal DNA…
Thought Leadership
Grail’s Galleri blood test screens for multiple cancer types using a single blood draw, analyzing DNA fragments for cancer signals and predicting their likely…
Greg O’Grady, professor of surgery at the University of Auckland and co-founder…
Gastroenterology’s growing reliance on anesthesia-supported sedation is emerging as a constraint on…
What Happens When Intelligence Becomes Part of the Infrastructure By Dr. Charles…
ARTIFICIAL INTELLIGENCE (AI)
Two machine learning approaches demonstrated 97.5% agreement in identifying colorectal neoplasia across 5,000 colonoscopy reports, according to research presented at…
Tech & Innovation
VIOVOC has received U.S. Patent No. 12,761,175 for technology designed to detect volatile organic compounds (VOCs) in bathroom air and translate these signals into personalized dietary…
Editor's Picks
Grail’s Galleri blood test screens for multiple cancer types using a single…
Business
Lucid Diagnostics has begun receiving Medicare payments for its EsoGuard esophageal DNA…
Exponential Tech
VIOVOC has received U.S. Patent No. 12,761,175 for technology designed to detect…
Leadership
A new study published in Gastroenterology highlights gaps in ambulatory training for…
Patient Trends
A new population-based study published in Clinical Gastroenterology and Hepatology evaluated the…
